Multicentre general practitioner assessment of 'Tenormin' and methyldopa.
J Int Med Res
; 7(4): 324-7, 1979.
Article
in En
| MEDLINE
| ID: mdl-488522
ABSTRACT
A large scale study in general practice was set up to investigate the effects of transferring hypertensive patients from treatment with usually less than 1 g daily of methyldopa to atenolol ('Tenormin') 100 mg daily. The results demonstrate an improvement in blood pressure control with atenolol treatment and a reduction in the incidence of side-effects. The simple dosage regime, combined with proven effectiveness and a relative lack of side-effects makes atenolol a useful treatment for the hypertensive patient.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Propanolamines
/
Atenolol
/
Hypertension
/
Methyldopa
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Int Med Res
Year:
1979
Document type:
Article